Artiva Biotherapeutics (ARTV) Change in Cash (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Change in Cash data on file, last reported at -$5.7 million in Q1 2026.

• On a quarterly basis, Change in Cash rose 40.34% year-over-year to -$5.7 million in Q1 2026; TTM through Mar 2026 was -$9.4 million, a 46.32% increase from a year earlier, with the FY2025 full-year figure at -$13.3 million, changed 0.47% from the prior year.
• Change in Cash for Q1 2026 stood at -$5.7 million, down from $1.2 million in the prior quarter.
• Over the last five years, Change in Cash for ARTV reached as high as $21.6 million in Q3 2024 and fell as low as -$15.6 million in Q4 2024.
• Historically, Change in Cash has averaged -$3.0 million across 4 years, with a median of -$5.3 million in 2024.
• On a YoY basis, Change in Cash climbed as much as 107.62% in 2025 and fell as far as 113.68% in 2025.
• Year by year, Change in Cash stood at -$12.4 million in 2023, then retreated by 26.37% to -$15.6 million in 2024, then jumped by 107.62% to $1.2 million in 2025, then plunged by 581.64% to -$5.7 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$5.7 million in Q1 2026, $1.2 million in Q4 2025, and -$3.0 million in Q3 2025.